電話

Consultation Info.:049-228-3411

Number Info.:049-228-3400

▶Contact information

Department of Hematology

November 15,2021 Update

Introduction

Ten years have passed since I was appointed to this department in July 2007. Since then, we have been aiming to create a facility that can comprehensively treat all blood diseases, from hematological malignancies such as leukemia, malignant lymphoma and multiple myeloma, to anemia and other general hematological diseases. During the past decade, research on the molecular pathogenesis of blood diseases has progressed dramatically, and the development of new therapeutic drugs has progressed and introduced into the clinics. As a result, the improvement in the treatment outcomes for hematological malignancies over the last ten years has been remarkable. We have established a system that allows our facility to practice state-of-the-art medical care without being late in the flow. In addition to a medical treatment system where we can practical treatments from normal chemotherapy, to all kinds of hematopoietic stem cell transplantation and we have developed into one of the leading blood care facilities in Japan, which can also conduct early clinical trials with non-approved drugs. At the same time, we have been trying to develop a team medical system with multi-disciplinary roles, as well as patient-oriented medical care. There is consistency of activity with the establishment of seminars and public lectures that are easy for the patient advocacy group to understand.

In order to practice such advanced medicine, it is essential to improve the level of the individuals who contribute it within the entire organization, and it is necessary for them to obtain a medical degree along with the qualifications of a specialist of internal medicine and hematology. To achieve this, we strive to disseminate our research results not only domestically but also internationally without neglecting our daily efforts. The motto of our Department of Hematology is to "Learn about medical care, education and research with Vision, Passion, and Mission". We would like to accept young doctors who aim to learn hematology and as many patients as possible, and we strive to be a base for blood treatments centering on hematological malignancies.

The Department of Hematology at Saitama Medical Center,Saitama Medical University promotes the practice of medical treatment with a high degree of satisfaction for the patient, and we promote education with a wide international perspective for young physicians and students who are responsible for the next generation. We want to practice better blood treatment and endeavor to contribute to society through these kinds of daily activities.

Patient care at our department

Our section has total34 beds, including 26 in a sterilized ward, and is capable of treating all blood diseases, as well as hematological malignancies and general diseases. We are certified with the Japan Marrow Donor Program, thus we can perform all kinds of hematopoietic stem cell transplantation. It is one of the leading facilities in Saitama Prefecture as well as Japan, and we are actively conducting clinical trials. It is very important to provide medical care covering a wide range of diseases for for the treatment of blood diseases,therefore,we aim to provide high-quality medical care by accepting a wide range of emergency cases, including acute leukemia and other diseases, with flexibility.

As a basic policy for the therapeutic approaches, we select a treatment options on a scientific basis (Evidence Based Medicine) according to globally approved clinical data, we then explain the medical policy sufficiently to the patient and family, and obtain his or her agreement, and then we prioritize the medical care that they can receive with peace of mind.

In recent years, a variety of new drugs have been developed and applied in practice and are now being incorporated into the standard treatment for blood diseases. Our department actively uses new therapeutic drugs and immunotherapy which have been approved for insurance coverage. We are also contributing to the improvement of the treatment results for blood diseases by promoting clinical trials which we have led and through multi-facility joint testing at JCOG and JALSG and other trialgroups in Japan. In the same way, we are often selected as an implementation facility for clinical trials for new drugs that are not yet approved for medical treatment of blood diseases on a nationwide scale, and we conduct clinical trials for a number of new drugs. In this way, we are committed to providing a wide range of treatment options, ranging from normal standard treatments to clinical trials.

We are focusing not only on inpatient care but also on outpatient treatment. If patients are able to attend outpatient treatment and need chemotherapy with a blood transfusion or an anticancer agent, then that quality of life is preferred, and we actively choose to treat them as outpatients. We also cooperate with other departments in the hospital. Our hospital has one of the most comprehensive perinatal, maternal and child care centers in Japan, and we have experienced many cases of diagnosis and treatment of blood abnormalities associated with pregnancy. The most common cases of hematological malignancy are malignant lymphoma, but for the diagnosis of malignant lymphoma, Professor Junichi Tamaru, the Department of Pathology in our hospital, is one of the most prominent pathologist in Japan, and we regularly conduct conferences with the pathology department and aim for accurate diagnoses based on clinical and pathological information both.

Main diseases

  • Acute leukemia (Acute myeloid leukemia, Acute lymphocytic leukemia, Adult T-cell leukemia)
  • Chronic leukemia (Chronic myeloid leukemia, Chronic lymphocytic leukemia)
  • Myelodysplastic syndromes
  • Myeloproliferative neoplasms(Essential thrombocythemia, Poly polycythemia, Primary myelofibrosis)
  • Malignant lymphoma (Hodgkin's lymphoma, non-Hodgkin's lymphoma, [Diffuse large B-cell lymphoma, Follicular lymphoma, Mantle cell lymphoma, MALT lymphoma, Burkitt lymphoma, Splenic marginal lymphoma, Adult T-cell lymphoma, peripheral T-cell lymphoma],etc)
  • Multiple myeloma, macroglobulin, plasma cell carcinoma
  • Anemia (Iron deficiency anemia, Megakoculblastic anemia, Hemolytic anemia, Paroxysmal nocturnal hemoglobinuria)
  • Aplastic anemia, Pure red cell aplasia
  • Blood clotting disorders (Hemophilia, Acquired hemophilia, Coagulation factor deficiency)
  • Idiopathic thrombocytopenia purpura
  • Thrombotic thrombocytopenic purpura
  • Disseminated intravascular coagulation
  • Thrombasthenia
 

Target Symptoms

  • Issues found in health checkups, abnormalities in blood count, hypercytosis, cytopenia(leukocytosis/leukopenia/neutropenia/polycythemia/plethora/erythropenia/anemia/ thrombocytosis/thrombocytopenia/pancytopenia)
  • Lymph node swelling
  • Enlarged spleen
  • Sustained fever, repeated fever, repeated infections, fever of unknown origin(fever that lasts more than three weeks after a hospital exam and for which the cause is unknown)
  • Bleeding tendencies (abnormal bleeding, hemostatic difficulties, bruises, purpura, petechia)
  • Anemia (malaise, weakness, shortness of breath, dizziness, etc.)
 

Treatment results

Number of inpatient hospitalizations 2020
Disease name (Number of cases)
Acute leukemia 124
Chronic leukemia 5
Malignant lymphoma 239
Multiple myeloma 52
Myelodysplastic syndrome 12
Aplastic anemia 1
Idiopathic thrombocytopenia purpura 6
Number of outpatients in 2020
Disease name (Number of cases)
Acute leukemia 23
Chronic leukemia 13
Malignant lymphoma 117
Multiple myeloma 21
Myelodysplastic syndrome 33
Aplastic anemia 3
Idiopathic thrombocytopenia purpura 17

診療スタッフ

Name Job Title Position Specialized Field Credentials
木崎 昌弘
(Kizaki Masahiro)
血液内科スタッフ001
Professor Chief of Clinical Services, Department of Hematology
Chief of Research, Department of Hematology
Chief of Education, Department of Hematology
Leukemia
Myelodysplastic syndromes
Multiple myeloma
Fellow of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Society of Hematology
多林 孝之
(TabayashiTakayuki)
血液内科スタッフ003
Associate Professor Vice-Chief of Clinical Services, Demartment of Hematology
Manager of Outpatient Services, Department of Hematology
Vice-Chief of Research, Department of Hematology
Multiple myeloma
Malignant lymphoma
Leukemia
Fellow of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Society of Hematology
Diplomate, Subspecialty Board of Medical Oncology, JSMO
阿南 朋恵
(Anan Tomoe)
血液内科スタッフ007
Instructor Manager of Inpatient Services, Department of Hematology Hematopoietic stem cell transplantation
Myelodysplastic syndromes
Multiple myeloma
Fellow of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Society of Hematology
木村 勇太
(Kimura Yuta)
血液内科スタッフ005
Instructor Manager of Residency Programs, Department of Hematology Malignant lymphoma
Anemia
Hematopoietic stem cell transplantation
Board Certified Member of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Society of Hematology
高橋 康之
(Takahashi Yasuyuki)
血液内科スタッフ006
Instructor Vice-Chief of Education, Department of Hematology Multiple myeloma
Anemia
Malignant lymphoma
Board Certified Member of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Society of Hematology
永沼 謙
(Naganuma Ken)
血液内科スタッフ009
Instructor Multiple myeloma
Leukemia
Malignant lymphoma
坂田 憲幸
(Sakata Noriyuki)
血液内科スタッフ
Instructor Leukemia
Malignant lymphoma
Multiple myeloma
川田 泰輔
(Kawada Taisuke)
血液内科スタッフ
Instructor Malignant lymphoma
Multiple myeloma
Leukemia
久保田 寧
(Kubota Yasushi)
血液内科スタッフ
Professor Leukemia
Hematopoietic stem cell transplantation
Transfusion medicine
Fellow of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Society of Hematology
Board Certified Member of the Japan Society for Hematopoetic Cell Transplantation
The Japan Society of Transfusion Medicine and Cell Therapy Authorized Doctor
Board Certified Doctor of the Japanese Society on Thrombosis and Hemostasis
中世古 玲子
(Nakaseko Reiko)
血液内科スタッフ011
Visiting Associate Professor Hematopoietic stem cell transplantation
Platelet diseases
Waldenstrom's macroglobulinemia
Fellow of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Society of Hematology
Board Certified Member of the Japan Society for Hematopoetic Cell Transplantation
富川 武樹
(Tomikawa Tatsuki)
血液内科スタッフ004
Visiting Assistant Professor Hematopoietic stem cell transplantation
Anemia
Malignant lymphoma
Fellow of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Society of Hematology
Board Certified Member of the Japan Society for Hematopoetic Cell Transplantation
三ツ橋 雄之
(Mitsuhashi Takayuki)
血液内科スタッフ013
Visiting Assistant Professor Hematopathology
Laboratory medicine
Councilor of the Japanese Society for Laboratory Hematology

Outpatient clinic

Department of Hematology
  Monday Tuesday Wednesday Thursday Friday Saturday
午前
初診
FAX診療予約制
多林 孝之
(Tabayashi Takayuki)

FAX診療予約制
木崎 昌弘
(Kizaki Masahiro)

FAX診療予約制
木崎 昌弘
(Kizaki Masahiro)

再診
髙橋 康之
(Takahasi Yasuyuki)
木村 勇太
(Kimura Yuta)
多林 孝之
(Tabayashi Takayuki)
移植後外来
中世古(渡部)玲子
(Nakaseko Reiko)
多林 孝之
(Tabayashi Takayuki)




富川 武樹
(Tomikawa Tatsuki)


午後
再診
多林 孝之
(Tabayashi Takayuki)
木村 勇太
(Kimura Yuta)
血液凝固外来
山本 晃士
(Yamamoto Koji)
富川 武樹
(Tomikawa Tatsuki)
多林 孝之
(Tabayashi Takayuki)




久保田 寧
(Kubota Yasushi)


・初診は月曜日・水曜日・金曜日の受付です。
・初診外来はFAX診療予約申込(FAX診療予約サービス)による予約制となります。医療機関からの紹介申込みとなります。

To the Medical Institutions

We treat all blood diseases, from hematological malignancies including acute leukemia, chronic leukemia, malignant lymphoma, multiple myeloma, myelodysplastic syndrome, to aplastic anemia, idiopathic thrombocytopenia purpura disease, myelofibrosis, coagulation disorders, EB viral infections, and cytomegalovirus infections, and other non-neoplastic diseases. Please refer patients to our department if they are suspected of having a blood diseases such as an abnormality in their blood couns or specific symptoms, if they have been diagnosed with a hematological malignancy in a pathological tissue diagnosis, or if they are relocating close to our hospital for medical treatment of a blood diseases. If they have a medical history in another hospital, they should bring their doctor's information (referral letter). That makes it possible to perform the medical treatment smoothly, so they should bring as much as possible.

We accept first visits on Saturdays, but there are several limitation that cannot be examined of genetic and bone marrow examinations necessary for diagnosing blood diseases. If necessary, we may ask them to visit again on weekdays from Monday to Friday. The doctor will instruct them at the time of their consultation.

Our hospital is a transplant facility accredited by the Japan Marrow Donor Program. In addition to transplantation of hematopoietic stem cells from related and unrelated donors umbilical cord blood transplantation from the Japan Marrow Donor Program donors are also actively utilized, if adaptable.

We also conduct a number of clinical trials. If you have patients who are interested in a clinical trial for a target diseases, we would appreciate it if you could refer them to us. In this case, we would like to ask you to provide their medical information.

We also provide second opinions for outpatients. The second opinion is separate from the outside frame of medical insurance, so we will have enough time in the second opinion frame for the patients who want our second opinion. We would ask that you apply for a visit to the specific second opinion outpatient clinic instead of for the regular outpatient clinics.

In the case of an emergency, etc., we will respond whenever possible even when outside the initial admission time. Please contact us by phone (049-228-3569) at the outpatient clinic until 17:00 on weekdays and Saturdays. Nighttime and holiday correspondence is done via the duty doctor. Please call us at the nighttime and holiday telephone reception (049-228-3595) at our hospital.

埼玉医科大学バナー 埼玉医科大学看護学校バナー